Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Magic mushroom therapy shows promise for depression

NCT ID NCT05227612

First seen Dec 29, 2025 · Last updated May 20, 2026 · Updated 21 times

Summary

This early study tested whether combining psilocybin (the active ingredient in magic mushrooms) with cognitive behavioral therapy is safe and helpful for people with major depression. Sixteen adults received two doses of psilocybin along with 12 therapy sessions. The goal was to see if people would accept the treatment and if it could reduce depressive symptoms.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • UCLA Semel Institute

    Los Angeles, California, 90095, United States

Conditions

Explore the condition pages connected to this study.